REFERENCES
- Bray F, Sankila R, Ferlay J, Parkin DM: Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer. 2002;38:99–166.
- Welsh TJ, Green RH, Richardson D, Waller D, O'Byrne KJ, Bradding P: Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer. J Clin Oncol. 2005;23:8959–8967.
- Galli SJ: New approaches for the analysis of mast cell maturation, heterogeneity, and function. Fed Proc. 1987;47:1906–1914.
- Ghiara P, Boraschi D, Scapigliati G, Taddei C, Tagliabue A: In vitro generated mast cells express natural cytotoxicity against tumor cells. Immunology 1985;55:317–324.
- Henderson WR, Chi EY, Jong EC, Klebanoff SJ: Mast cell-mediated tumor cell cytotoxicity—role of the peroxidase system. J Exp Med. 1981;153:520–533.
- Aaltomaa S, Lipponen P, Papinaho S, Kosma VM: Mast cells in breast cancer. Anticancer Res. 1993;13:785–788.
- Lachter J, Stein M, Lichtig C, Eidelman S, Munichor M: Mast cells in colorectal neoplasias and premalignant disorders. Dis Colon Rectum. 1995;38:290–293.
- Dimitiradou V, Koutsilieris M: Mast cell-tumor interactions: for or against tumour growth and metastasis. Anticancer Res. 1997;17:1541–1549.
- Tomita M, Matsuzaki Y, Edagawa M, Shimizu T, Hara M, Onitsuka T: Distribution of mast cells in mediastinal lymph nodes from lung cancer patients. World J Surg Oncol. 2003;1:25–29.
- Meininger CJ: Mast cells and tumor-associated angiogenesis. Chem Immunol. 1995;62:239–257.
- Takanami I, Takeuchi K, Naruke M: Mast cell density is associated with angiogenesis and poor prognosis in pulmonary adenocarcinoma. Cancer. 2000;88:2686–2692.
- Imada A, Shijubo N, Kojima H, Abe S: Mast cells correlate with angiogenesis and poor outcome in stage I lung adenocarcinoma. Eur Respir J. 2000;15:1087–1093.
- Nagata M, Shijubo N, Walls AF, : Chymase-positive mast cells in small sized adenocarcinoma of the lung. Virchows Arch. 2003;443:565–573.
- Bingle L, Brown NJ, Lewis CE: The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol. 2002;196:254–265.
- Hartveit F, Thoresen S, Tangen M, Maartmann-Moe H: Mast cell changes and tumour dissemination in human breast carcinoma. Invasion Metastasis. 1984;4:146–155.
- Duncan LM, Richards LA, Mihm MC Jr: Increased mast cell density in invasive melanoma. J Cutan Pathol. 1998;25:11– 15.
- Donhuijsen K, Sastry M, Volker B, Leder LD: Mast cell frequency in soft tissue tumors: relation to type and grade of malignancy. Pathol Res Prac. 1992;188:61–66.
- Gooch JL, Lee AV, Yee D: Interleukin 4 inhibits growth and induces apoptosis in human breast cancer cells. Cancer Res. 1998;58:4199–4205.
- Meininger CJ: Mast cells and tumor-associated angiogenesis. Chem Immunol. 1995;62:239–257.
- Stoyanov E, Uddin M, Mankuta D, Dubinett SM, Levi-Schaffer E: Mast cells and histamine enhance the proliferation of non-small cell lung cancer cells. Lung Cancer. 2012;75:38–44.
- Blair RJ, Meng H, Marchese MJ, : Human mast cells stimulate vascular tube formation: tryptase is a novel, potent angiogenic factor. J Clin Invest. 1997;99:2691–2700.
- Grutzkau A, Kruger-Krasagakes S, Baumeister H, : Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF206. Mol Biol Cell. 1998;9:875–884.
- Sorbo J, Jakobsson A, Norrby K: Mast-cell histamine is angiogenic through receptors for histamine1 and histamine2. Int J Exp Pathol. 1994;75:43–50.
- Qu Z, Liebler JM, Powers MR, : Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma. Am J Pathol. 1995;147:564–573.
- Azizkhan R, Azizkhan JC, Zetter BR, Folkman J: Mast cell heparin stimulates migration of capillary endothelial cells in vitro. J Exp Med. 1980;152:931–944.
- Gruber BL, Marchese MJ, Kew R: Angiogenic factors stimulate mast-cell migration. Blood. 1995;86:2488–2493.
- Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z: Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 1999;13:9–22.
- Shibusa T, Shijubo N, Abe S: Tumor angiogenesis and vascular endothelial growth factor expression in stage I lung adenocarcinoma. Clin Cancer Res. 1998;4:1483–1487.
- Shijubo N, Uede T, Kon S, : Vascular endothelial growth factor and osteopontin in stage I lung adenocarcinoma. Am J Respir Crit Care Med. 1999;160:1269–1273.
- Gruber BL, Marchese MJ, Kew R: Angiogenic factors stimulate mast-cell migration. Blood. 1995;86:2488–2493.
- Starkey JR, Crowle PK, Taubenberger S: Mast-cell deficient W/Wv mice exhibit a decreased rate of tumor angiogenesis. Int J Cancer. 1988;42:8–52.
- Weidner N, Semple JP, Welch WR, Follman J: Tumor angiogenesis and metastasis correlation in invasive breast carcinoma. N Engl J Med. 1991;324:1–8.
- Tomita M, Matsuzaki Y, Onitsuka T: Effect of mast cells on tumor angiogenesis in lung cancer. Ann Thorac Surg. 2000;69:1686–1690.